Table 2.
Level of heme oxygenase-1 (HO-1), hemoglobin (HGB), and regional QSM values (*10−2) in patients with PD and CG.
| PD | CG | p | |
|---|---|---|---|
| N | 32 | 26 | / |
| HO-1(pg/ml) | 85.685 ± 3.868 | 45.739 ± 3.686 | 0.000** |
| HGB (g/l) | 127.500 ± 2.673 | 135.192 ± 1.827 | 0.044* |
| QSM value of ROIs | |||
| SN | 8.181 ± 1.548 | 6.623 ± 1.061 | 0.000** |
| RN | 7.530 ± 2.003 | 5.657 ± 1.590 | 0.002** |
| CN | 2.627 ± 0.848 | 2.410 ± 0.642 | 0.351 |
| GP | 7.700 ± 1.600 | 7.002 ± 1.071 | 0.104 |
| PUT | 3.568 ± 1.205 | 2.524 ± 0.811 | 0.002** |
QSM, quantitative susceptibility mapping; SN, substantia nigra; RN, red nucleus; CN, the head of caudate nucleus; GP, globus pallidus; PUT, putamen. *PD vs. CG p < 0.05; **PD vs. CG p < 0.01.